These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 6415401)

  • 1. Pharmacophor requirements of the aldose reductase inhibitor site.
    Kador PF; Sharpless NE
    Mol Pharmacol; 1983 Nov; 24(3):521-31. PubMed ID: 6415401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The aldose reductase inhibitor site.
    Kador PF; Kinoshita JH; Sharpless NE
    Metabolism; 1986 Apr; 35(4 Suppl 1):109-13. PubMed ID: 3083201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldose reductase inhibition by anti-allergy drugs.
    Kador PF; Sharpless NE; Goosey JD
    Prog Clin Biol Res; 1982; 114():243-59. PubMed ID: 6131432
    [No Abstract]   [Full Text] [Related]  

  • 4. Irreversible aldose reductase inhibitors.
    Kador PF; Gurley RC; Ares JJ; Miller DD
    Prog Clin Biol Res; 1987; 232():353-65. PubMed ID: 3112788
    [No Abstract]   [Full Text] [Related]  

  • 5. Differences in the susceptibility of various aldose reductases to inhibition. II.
    Kador PF; Kinoshita JH; Tung WH; Chylack LT
    Invest Ophthalmol Vis Sci; 1980 Aug; 19(8):980-2. PubMed ID: 6773903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the nature of the charge transfer interaction at the aldose reductase inhibitor site.
    Kador PF; Nakayama T; Sato S; Smar M; Miller DD
    Prog Clin Biol Res; 1989; 290():237-50. PubMed ID: 2498900
    [No Abstract]   [Full Text] [Related]  

  • 7. Ponalrestat: a potent and selective inhibitor of bovine lens aldose reductase.
    Tuffin DP; Dingle A; Sennitt CM; Mirrlees DJ; Ward WH
    Prog Clin Biol Res; 1989; 290():221-35. PubMed ID: 2498899
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of lens-aldose reductase activity by brazilin and haematoxylin.
    Moon CK; Yun YP; Lee JH; Wagner H; Shin YS
    Planta Med; 1985 Feb; (1):66-7. PubMed ID: 3925476
    [No Abstract]   [Full Text] [Related]  

  • 9. [Aldose-reductase inhibitors and cataract formation (author's transl)].
    Keller G; Leuenberger PM
    Klin Monbl Augenheilkd; 1980 Apr; 176(4):514-5. PubMed ID: 6775130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An artificial intelligence approach to the study of the structural moieties relevant to drug-receptor interactions in aldose reductase inhibitors.
    Klopman G; Buyukbingol E
    Mol Pharmacol; 1988 Dec; 34(6):852-62. PubMed ID: 3143909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of lens aldose reductase by Labiatae flavonoids.
    Tomás-Barberán FA; López-Gómez C; Villar A; Tomás-Lorente F
    Planta Med; 1986 Jun; (3):239-40. PubMed ID: 3092256
    [No Abstract]   [Full Text] [Related]  

  • 12. 1-Benzopyran-4-one antioxidants as aldose reductase inhibitors.
    Costantino L; Rastelli G; Gamberini MC; Vinson JA; Bose P; Iannone A; Staffieri M; Antolini L; Del Corso A; Mura U; Albasini A
    J Med Chem; 1999 Jun; 42(11):1881-93. PubMed ID: 10354396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of aldehyde reductase by aldose reductase inhibitors.
    Sato S; Kador PF
    Biochem Pharmacol; 1990 Sep; 40(5):1033-42. PubMed ID: 2117925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibition of aldose reductase from the rat lens by flavonoids].
    Xie MZ; Shen ZF
    Yao Xue Xue Bao; 1986 Oct; 21(10):721-4. PubMed ID: 3107341
    [No Abstract]   [Full Text] [Related]  

  • 15. Structure-activity relationship of aldose reductase inhibitors based on X-ray crystal structures of oxazolecarbamate derivatives.
    Ishida T; In Y; Ohishi H; Yamamoto D; Inoue M; Tanaka C; Ueno Y; Ohmomo Y; Kanda N; Tanaka A
    Mol Pharmacol; 1988 Sep; 34(3):377-87. PubMed ID: 3138530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a new aldose reductase inhibitor on various tissues in vitro.
    Terashima H; Hama K; Yamamoto R; Tsuboshima M; Kikkawa R; Hatanaka I; Shigeta Y
    J Pharmacol Exp Ther; 1984 Apr; 229(1):226-30. PubMed ID: 6423811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synthesis and pharmacologic study of several spirohydantoins: relation to conformation].
    Courtoison JC; Coudert P; Couquelet J; Tronche P; Jonadet M; Bastide P
    Farmaco Sci; 1988 Feb; 43(2):153-60. PubMed ID: 3134252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of aldose reductase activities by kampo medicines.
    Aida K; Shindo H; Tawata M; Onaya T
    Planta Med; 1987 Apr; 53(2):131-5. PubMed ID: 3110810
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis, activity, and molecular modeling of a new series of tricyclic pyridazinones as selective aldose reductase inhibitors.
    Costantino L; Rastelli G; Vescovini K; Cignarella G; Vianello P; Del Corso A; Cappiello M; Mura U; Barlocco D
    J Med Chem; 1996 Oct; 39(22):4396-405. PubMed ID: 8893834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, activity, and molecular modeling of new 2, 4-dioxo-5-(naphthylmethylene)-3-thiazolidineacetic acids and 2-thioxo analogues as potent aldose reductase inhibitors.
    Fresneau P; Cussac M; Morand JM; Szymonski B; Tranqui D; Leclerc G
    J Med Chem; 1998 Nov; 41(24):4706-15. PubMed ID: 9822541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.